Rentokil Initial (LON:RTO - Get Free Report)'s stock had its "outperform" rating reiterated by investment analysts at Royal Bank Of Canada in a research report issued on Friday, MarketBeat reports. They currently have a GBX 440 ($5.81) target price on the stock. Royal Bank Of Canada's target price points to a potential upside of 22.05% from the company's current price.
Separately, Deutsche Bank Aktiengesellschaft raised their target price on Rentokil Initial from GBX 425 ($5.61) to GBX 435 ($5.75) and gave the company a "buy" rating in a report on Monday, July 21st.
Check Out Our Latest Research Report on RTO
Rentokil Initial Stock Down 5.0%
Shares of LON:RTO opened at GBX 360.50 ($4.76) on Friday. The business has a 50-day moving average price of GBX 352.87 and a 200 day moving average price of GBX 359.52. The company has a current ratio of 1.04, a quick ratio of 1.76 and a debt-to-equity ratio of 113.35. The company has a market capitalization of £9.03 billion, a price-to-earnings ratio of 23.12, a PEG ratio of 0.56 and a beta of 0.55. Rentokil Initial has a 12-month low of GBX 306 ($4.04) and a 12-month high of GBX 502.40 ($6.64).
Insider Activity
In related news, insider Sally Johnson acquired 3,567 shares of the firm's stock in a transaction dated Monday, June 2nd. The stock was acquired at an average price of GBX 351 ($4.64) per share, for a total transaction of £12,520.17 ($16,539.19). Insiders own 0.32% of the company's stock.
About Rentokil Initial
(
Get Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.